A Phase 1 Study to Evaluate the Safety of KLN-1010, a Novel, In Vivo Gene Therapy to Generate Anti-BCMA CAR-T Cells in Patients with Relapsed and Refractory Multiple Myeloma

Project: Research

Project Details

StatusActive
Effective start/end date2/07/25 → 1/07/27

Keywords

  • Clinical Trials
  • KLN-001

Clinical Trial Phase

  • Phase I